KLI

Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-X-L inhibitor ABT-263 in KRAS-mutant colorectal cancers

Metadata Downloads
Publisher
CANCER LETTERS
Language
영어
ISSN
0304-3835
Citation Volume
497
Citation Start Page
123
Citation End Page
136
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.